NCT04385407View on ClinicalTrials.gov

Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Chronic Hepatitis C Virus Infection
Interventions
DRUG

Sofosbuvir + Simeprevir + Ribavirin

All Listed Sponsors
lead

Beni-Suef University

OTHER

NCT04385407 - Sofosbuvir With Ribavirin or Simeprevir With HCV GT4 Egyptian Patients | Biotech Hunter | Biotech Hunter